Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2019
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 25 Oct 2018 Planned End Date changed from 1 Aug 2019 to 1 Sep 2019.
- 25 Oct 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Sep 2019.
- 12 Oct 2018 New trial record